Price$14.26-0.61 (-4.10%)
2026-01-282026-05-01
News · 26 weeks41-50%
2025-11-092026-05-03
Mix2790d
- Insider13(48%)
- Other5(19%)
- SEC Filings4(15%)
- Earnings3(11%)
- Dividends1(4%)
- Leadership1(4%)
Latest news
25 items- SECSEC Form DEFA14A filed by Surgery Partners Inc.DEFA14A - Surgery Partners, Inc. (0001638833) (Filer)
- SECSEC Form DEF 14A filed by Surgery Partners Inc.DEF 14A - Surgery Partners, Inc. (0001638833) (Filer)
- PRSurgery Partners, Inc. Announces First Quarter 2026 Earnings Release Date and Conference Call DetailsBRENTWOOD, Tenn., April 17, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its first quarter 2026 results before the market opens on Tuesday, May 5, 2026, to be followed by a conference call at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until May 19, 2026): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13760194 Interested investor
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Surgery Partners Inc.SCHEDULE 13G/A - Surgery Partners, Inc. (0001638833) (Subject)
- INSIDERChief Human Resources Officer Burkhalter Danielle sold $44,507 worth of shares (3,469 units at $12.83), decreasing direct ownership by 4% to 76,864 units (SEC Form 4)4 - Surgery Partners, Inc. (0001638833) (Issuer)
- INSIDERChief Strategy Officer Brittenham Marissa sold $45,859 worth of shares (3,657 units at $12.54), decreasing direct ownership by 4% to 94,196 units (SEC Form 4)4 - Surgery Partners, Inc. (0001638833) (Issuer)
- INSIDERChief Executive Officer Evans Jason Eric sold $254,388 worth of shares (20,400 units at $12.47), decreasing direct ownership by 2% to 920,386 units (SEC Form 4)4 - Surgery Partners, Inc. (0001638833) (Issuer)
- INSIDERChief Financial Officer Doherty David T sold $110,838 worth of shares (8,867 units at $12.50), decreasing direct ownership by 4% to 221,679 units (SEC Form 4)4 - Surgery Partners, Inc. (0001638833) (Issuer)
- INSIDERChief Admin & Dev Officer Baldock Jennifer sold $76,360 worth of shares (5,798 units at $13.17), decreasing direct ownership by 2% to 326,474 units (SEC Form 4)4 - Surgery Partners, Inc. (0001638833) (Issuer)
- PRSurgery Partners, Inc. Names Lloyd Dean to Board of DirectorsBRENTWOOD, Tenn., March 12, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company") recently announced that Lloyd Dean has been appointed to serve as an independent director on its Board of Directors. Mr. Dean is the former Chief Executive Officer of CommonSpirit Health, one of the largest nonprofit health systems in the United States, with 142 hospitals, over 1,000 care sites, 25,000 physicians, and 150,000 employees across 21 states. From 2019 to 2022, he led the formation and integration of CommonSpirit, advancing clinical quality, operational performance, and community health initiatives at national scale. Prior to CommonSpirit, Mr. Dean ser
- PROrtelius Delivers Open Letter to Surgery Partners StockholdersSurgery Board and Management Team Have Presided Over the Vast Destruction of Value and Must Be Held Accountable Letter Outlines Multiple Paths to Building and Unlocking Intrinsic Value for Stockholders Divestiture of Surgical Hospitals Should Generate Billions of Dollars in Asset Sales, Enabling Stock Repurchase and Balance Sheet Deleveraging Ortelius Advisors, L.P. today issued the following open letter to stockholders of Surgery Partners, Inc. (NASDAQ:SGRY). March 10, 2026 Fellow Stockholders, Ortelius Advisors, L.P. ("Ortelius" or "we") believes that Surgery Partners, Inc. ("Surgery" or the "Company") has significant upside potential, based on its high-quality assets, favorab
- INSIDERChief Executive Officer Evans Jason Eric sold $158,061 worth of shares (11,462 units at $13.79) and was granted 278,106 shares, increasing direct ownership by 40% to 940,786 units (SEC Form 4)4 - Surgery Partners, Inc. (0001638833) (Issuer)
- INSIDERChief Admin & Dev Officer Baldock Jennifer was granted 106,307 shares and sold $138,123 worth of shares (10,082 units at $13.70), increasing direct ownership by 41% to 332,272 units (SEC Form 4)4 - Surgery Partners, Inc. (0001638833) (Issuer)
- INSIDERChief Financial Officer Doherty David T sold $201,704 worth of shares (14,574 units at $13.84) and was granted 141,743 shares, increasing direct ownership by 123% to 230,546 units (SEC Form 4)4 - Surgery Partners, Inc. (0001638833) (Issuer)
- INSIDERChief Human Resources Officer Burkhalter Danielle sold $105,210 worth of shares (7,736 units at $13.60) and was granted 43,230 shares, increasing direct ownership by 79% to 80,333 units (SEC Form 4)4 - Surgery Partners, Inc. (0001638833) (Issuer)
- INSIDERChief Strategy Officer Brittenham Marissa sold $120,354 worth of shares (8,785 units at $13.70) and was granted 43,230 shares, increasing direct ownership by 54% to 97,853 units (SEC Form 4)4 - Surgery Partners, Inc. (0001638833) (Issuer)
- INSIDERAmerican Group President Webb William Trenton sold $28,654 worth of shares (2,066 units at $13.87) and was granted 31,892 shares, increasing direct ownership by 40% to 104,347 units (SEC Form 4)4 - Surgery Partners, Inc. (0001638833) (Issuer)
- INSIDERCOO & National Group President Oppenheimer Justin Robert was granted 42,523 shares, increasing direct ownership by 55% to 120,259 units (SEC Form 4)4 - Surgery Partners, Inc. (0001638833) (Issuer)
- INSIDERNew insider Dean Lloyd H claimed no ownership of stock in the company (SEC Form 3)3 - Surgery Partners, Inc. (0001638833) (Issuer)
- PRSurgery Partners, Inc. to Present at Upcoming Investor ConferenceBRENTWOOD, Tenn., March 09, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), is scheduled to meet with investors at the Barclays 28th Annual Global Healthcare Conference, including a presentation on Tuesday, March 10, 2026, at 2:30 p.m. (Eastern Time). Interested investors and other parties may listen to a simultaneous webcast of the event through the investor relations section of the company's website at www.surgerypartners.com. The replay will also be available on this same website for a limited time following the call. To learn more about Surgery Partners, please visit the Company's website at www.surgerypartners.com. Surgery Partner
- PRZIEGLER ADVISES PREFERRED VASCULAR GROUP ON ITS ACQUISITION BY SURGERY PARTNERSCHICAGO, March 4, 2026 /PRNewswire/ -- Ziegler, a specialty investment bank, is pleased to announce that it served as the exclusive financial advisor to Preferred Vascular Group (PVG) in connection with its acquisition by Surgery Partners (NASDAQ:SGRY), a leading operator of surgical facilities and ancillary services. Founded in 2005, PVG is a leading Ambulatory Surgical Center (ASC) operator focused specifically on dialysis access procedures, with eight ASCs in Georgia and Ohio. Don Holton founded the Company after identifying a gap in dialysis access care and seeking to fill a
- SECSEC Form 10-K filed by Surgery Partners Inc.10-K - Surgery Partners, Inc. (0001638833) (Filer)
- SECSurgery Partners Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Surgery Partners, Inc. (0001638833) (Filer)
- PRSurgery Partners, Inc. Announces Fourth Quarter and Full Year 2025 Results; Sets 2026 Guidance; Announces Share Repurchase ProgramBRENTWOOD, Tenn., March 02, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter and Full Year 2025 Financial Highlights (All comparisons are year-over-year unless otherwise noted) Revenue increased 2.4% for the fourth quarter and 6.2% for the full year Same-facility revenues increased 3.5% for the fourth quarter and 4.9% for the full year Surgical cases decreased 2.1% for the fourth quarter and increased 2.0% for the full year Same-facility cases increased 1.3% for the fourth
- PRSurgery Partners, Inc. Announces Fourth Quarter 2025 Earnings Release Date and Conference Call DetailsBRENTWOOD, Tenn., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its fourth quarter 2025 results after market close on Monday, March 2, 2026, to be followed by a conference call on Tuesday, March 3, 2026 at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until March 17, 2026): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13758
SGRY FAQ
7 questionsWhat does Surgery Partners Inc. do?
Surgery Partners, Inc., through its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company operates through Surgical Facility Services and Ancillary Services segments. Its surgical facilities comprise ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including gastroenterology, general surgery, ophthalmology, orthopedics, and pain management. The company's surgical hospitals also provide ancillary services, such as diagnostic imaging, pharmacy, laboratory...Where does SGRY stock trade?
Surgery Partners Inc. (SGRY) is listed on NASDAQ.What sector and industry is SGRY in?
Surgery Partners Inc. operates in the Health Care sector, Hospital/Nursing Management industry.When did Surgery Partners Inc. go public?
Surgery Partners Inc. (SGRY) completed its IPO in 2015.What are analysts saying about SGRY?
Surgery Partners Inc. has had 8 recent analyst actions on file. The most recent action was from Analyst: Neutral with a $2700.00 price target on 2025-09-18. Recent price targets range from $2700.00 to $3800.00.What companies are similar to SGRY?
Notable peers in the same industry include HCA (HCA Healthcare Inc.), THC (Tenet Healthcare Corporation), ENSG (The Ensign Group Inc.), EHC (Encompass Health Corporation), UHS (Universal Health Services Inc.). Compare SGRY side-by-side with any of them on Quantisnow.How can I track SGRY on Quantisnow?
Quantisnow aggregates Surgery Partners Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow SGRY to receive live email and push alerts on every new disclosure.